Clinical Trials · NCT06338553
GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
- Phase
- EARLY_Phase 1
- Recruitment status
- Recruiting
- Sponsor
- Vanderbilt University Medical Center
- Enrollment
- 24
- Start date
- Jun 2024
- Locations
- 1 site, United States
- Primary endpoint
- Investigate the impact of GLP-1Ra on postprandial glycemia in a pilot study